These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25656846)

  • 1. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
    Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
    Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel impact of EWI-2, CD9, and CD81 on TGF-β signaling in melanoma.
    Wang HX; Hemler ME
    Mol Cell Oncol; 2015 Oct; 2(1):. PubMed ID: 26989766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWI-2 regulates alpha3beta1 integrin-dependent cell functions on laminin-5.
    Stipp CS; Kolesnikova TV; Hemler ME
    J Cell Biol; 2003 Dec; 163(5):1167-77. PubMed ID: 14662754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing isoform complexity of human tetraspanins by optimized expression in Dictyostelium discoideum enables high-throughput functional read-out.
    Scheltz T; von Bülow J; Beitz E
    Protein Expr Purif; 2017 Jul; 135():8-15. PubMed ID: 28442431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.
    Bai X; Jing L; Li Y; Li Y; Luo S; Wang S; Zhou J; Liu Z; Diao A
    Cell Signal; 2014 Sep; 26(9):2030-9. PubMed ID: 24933703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.
    Kolesnikova TV; Kazarov AR; Lemieux ME; Lafleur MA; Kesari S; Kung AL; Hemler ME
    Neoplasia; 2009 Jan; 11(1):77-86, 4p following 86. PubMed ID: 19107234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.
    Stipp CS; Kolesnikova TV; Hemler ME
    J Biol Chem; 2001 Nov; 276(44):40545-54. PubMed ID: 11504738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β.
    Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C
    Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.
    Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
    Am J Pathol; 2014 Mar; 184(3):842-58. PubMed ID: 24412090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin protein contributions to cancer.
    Wang HX; Li Q; Sharma C; Knoblich K; Hemler ME
    Biochem Soc Trans; 2011 Apr; 39(2):547-52. PubMed ID: 21428937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRAK2 participates in a negative feedback loop to control TGF-β/Smads signaling by binding to type I TGF-β receptor.
    Yang KM; Kim W; Bae E; Gim J; Weist BM; Jung Y; Hyun JS; Hernandez JB; Leem SH; Park T; Jeong J; Walsh CM; Kim SJ
    Cell Rep; 2012 Nov; 2(5):1286-99. PubMed ID: 23122956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
    Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
    Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
    Halder SK; Beauchamp RD; Datta PK
    Neoplasia; 2005 May; 7(5):509-21. PubMed ID: 15967103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.
    Charrin S; Le Naour F; Labas V; Billard M; Le Caer JP; Emile JF; Petit MA; Boucheix C; Rubinstein E
    Biochem J; 2003 Jul; 373(Pt 2):409-21. PubMed ID: 12708969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRG1 modulates invasion and migration of glioma cell lines through TGF-β signaling pathway.
    Zhong D; He G; Zhao S; Li J; Lang Y; Ye W; Li Y; Jiang C; Li X
    Acta Histochem; 2015 Jul; 117(6):551-8. PubMed ID: 26049667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraspanins are involved in Schwann cell-axon interaction.
    Chernousov MA; Stahl RC; Carey DJ
    J Neurosci Res; 2013 Nov; 91(11):1419-28. PubMed ID: 24038174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TGF-β signaling in clear cell renal cell carcinoma cells.
    Boström AK; Lindgren D; Johansson ME; Axelson H
    Biochem Biophys Res Commun; 2013 May; 435(1):126-33. PubMed ID: 23618868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.